Anthony Alberg to Prospective Studies
This is a "connection" page, showing publications Anthony Alberg has written about Prospective Studies.
Connection Strength
0.854
-
The enduring need for prospective cohort studies to more completely characterize the tobacco-caused burden of cancer. Int J Cancer. 2021 09 01; 149(5):982-983.
Score: 0.112
-
A cohort study of personal and family history of skin cancer in relation to all-cause and cancer-specific mortality. Cancer Causes Control. 2021 Jan; 32(1):75-82.
Score: 0.108
-
A community-based study of nucleotide excision repair polymorphisms in relation to the risk of non-melanoma skin cancer. J Invest Dermatol. 2012 May; 132(5):1354-62.
Score: 0.059
-
Cigarette smoking and the risk of dying from tobacco-related malignancies by race. Anticancer Res. 2011 Nov; 31(11):3891-5.
Score: 0.058
-
Cruciferous vegetable intake and lung cancer risk: a nested case-control study matched on cigarette smoking. Cancer Epidemiol Biomarkers Prev. 2010 Oct; 19(10):2534-40.
Score: 0.053
-
The association between skin characteristics and skin cancer prevention behaviors. Cancer Epidemiol Biomarkers Prev. 2009 Oct; 18(10):2613-9.
Score: 0.050
-
Copy number variants of GSTM1 and GSTT1 in relation to lung cancer risk in a prospective cohort study. Ann Epidemiol. 2009 Aug; 19(8):546-52.
Score: 0.048
-
The risk of dying from lung cancer by race: a prospective cohort study in a biracial cohort in Charleston, South Carolina. Ann Epidemiol. 2009 May; 19(5):304-10.
Score: 0.048
-
Nonmelanoma skin cancer and risk for subsequent malignancy. J Natl Cancer Inst. 2008 Sep 03; 100(17):1215-22.
Score: 0.046
-
Carotenoids and the risk of developing lung cancer: a systematic review. Am J Clin Nutr. 2008 Aug; 88(2):372-83.
Score: 0.046
-
A prospective cohort study of rectal cancer risk in relation to active cigarette smoking and passive smoke exposure. Ann Epidemiol. 2008 Jan; 18(1):28-35.
Score: 0.043
-
Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate and the subsequent risk of developing colon cancer. Cancer Epidemiol Biomarkers Prev. 2000 May; 9(5):517-21.
Score: 0.026
-
Carotenoids, retinol, tocopherols, and prostate cancer risk: pooled analysis of 15 studies. Am J Clin Nutr. 2015 Nov; 102(5):1142-57.
Score: 0.019
-
Tobacco use and surgical outcomes in patients with head and neck cancer. Head Neck. 2016 May; 38(5):700-6.
Score: 0.018
-
Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies. Lancet Oncol. 2013 Sep; 14(10):1009-19.
Score: 0.016
-
Prediagnostic circulating follicle stimulating hormone concentrations and ovarian cancer risk. Int J Cancer. 2009 Aug 01; 125(3):674-9.
Score: 0.012
-
Serum concentrations of cytokines and lung cancer survival in African Americans and Caucasians. Cancer Epidemiol Biomarkers Prev. 2009 Jan; 18(1):215-22.
Score: 0.012
-
HDL-cholesterol and incidence of breast cancer in the ARIC cohort study. Ann Epidemiol. 2008 Sep; 18(9):671-7.
Score: 0.012
-
Smoking and risk of fatal prostate cancer in a prospective U.S. study. Urology. 2007 Apr; 69(4):721-5.
Score: 0.010
-
Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst. 2003 Aug 20; 95(16):1218-26.
Score: 0.008
-
Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer. Am J Epidemiol. 2003 Feb 15; 157(4):335-44.
Score: 0.008
-
Prospective study of carotenoids, tocopherols, and retinoid concentrations and the risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2002 May; 11(5):451-7.
Score: 0.007
-
A prospective study of plasma ascorbic acid concentrations and breast cancer (United States). Cancer Causes Control. 2000 Mar; 11(3):279-83.
Score: 0.006
-
Serum concentrations of organochlorine compounds and the subsequent development of breast cancer. Cancer Epidemiol Biomarkers Prev. 1999 Jun; 8(6):525-32.
Score: 0.006
-
Prospective study of serum micronutrients and ovarian cancer. J Natl Cancer Inst. 1996 Jan 03; 88(1):32-7.
Score: 0.005
-
Serum gonadotropins and steroid hormones and the development of ovarian cancer. JAMA. 1995 Dec 27; 274(24):1926-30.
Score: 0.005
-
A prospective study of endogenous hormones and breast cancer. Cancer Detect Prev. 1994; 18(2):79-85.
Score: 0.004
-
Prospective study of serum CA-125 levels as markers of ovarian cancer. JAMA. 1993 Mar 03; 269(9):1123-6.
Score: 0.004
-
Serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate and the risk of developing gastric cancer. Cancer Epidemiol Biomarkers Prev. 1993 Jan-Feb; 2(1):33-5.
Score: 0.004